Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Urology Focus|June 7, 2024
What About Variant Histologies in Bladder Cancer?Elizabeth Day, Javier Gavira, Jose C Tapia, et al.Atencion Primaria|October 17, 2013
[Prevalence and risk factors of urinary incontinence in women who visit the doctor with low back pain: multicentre study]Alberto Gavira Pavón, Carolina Walker Chao, Nicomedes Rodríguez Rodríguez, et al.International Journal of Cancer|February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and PortugalJose C Tapia, Javier Gavira, Diana Matthews, et al.Clinical Genitourinary Cancer|March 2, 2024
Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021Jose C Tapia, Freya Bosma, Javier Gavira, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 29, 2024
Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysisJose C Tapia, Javier Gavira, Georgia Anguera, et al.International Journal of Cancer|December 18, 2021
Ninety-day mortality and clinical outcomes of patients with solid tumours and COVID-19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective studyJose Carlos Tapia, Javier Gavira, Assumpció López, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2024
Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institutionJavier Gavira, Jose Carlos Tapia, Alejandra Romano, et al.Exploration of Targeted Anti-Tumor Therapy|October 28, 2024
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinomaLoubna Omri, Marie Naigeon, Ronan Flippot, et al.Cancer Immunology, Immunotherapy : CII|January 3, 2021
Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agentsCarlos Zamora, Mariona Riudavets, Georgia Anguera, et al.Journal of Gastrointestinal Cancer|January 4, 2024
Capecitabine-Related Thrombotic MicroangiopathyFrancisco J Pelegrín Mateo, Anna Dominguez Guasch, Jose Andrés Guerrero Pineda, et al.Pageof 2